China Wah Yan Healthcare : UPDATES ON (1) CONDITIONS FOR RESUMPTION OF TRADING; AND (2) AMENDMENTS TO THE DELISTING FRAMEWORK UNDER THE LISTING RULES

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

(Incorporated in Hong Kong with limited liability)

(Stock Code: 648)

UPDATES ON (1) CONDITIONS FOR RESUMPTION OF TRADING;

AND

(2) AMENDMENTS TO THE DELISTING FRAMEWORK UNDER

THE LISTING RULES

Reference is made to the announcement of China Wah Yan Healthcare Limited (the "Company") dated 27 November 2017 (the "Announcement") relating to the suspension of trading in the shares of the Company (the "Shares"). Unless otherwise defined, capitalised terms used in this announcement shall have the same meanings as those defined in the Announcement.

CONDITIONS FOR RESUMPTION OF TRADING IN THE SHARES

On 23 July 2018, the Company received a letter from the Stock Exchange, in which the Stock Exchange stated the following conditions for resumption of trading in the Shares (the "Resumption Conditions"):

• (i) publish all outstanding financial results in accordance with the Listing Rules and address any audit modifications; and

• (ii) announce all material information for the Company's shareholders and other investors to appraise the Company's position.

The Stock Exchange may modify the Resumption Conditions and/or impose further conditions as the Company's circumstances change.

AMENDMENTS TO THE DELISTING FRAMEWORK UNDER THE LISTING RULES

The amendments to the delisting framework under the Listing Rules will come into effect on 1 August 2018 (the "Effective Date") under which the Stock Exchange may delist an issuer after a trading suspension of 18 months.

As the Shares will have been suspended from trading for less than 12 months as at the Effective Date, under Rule 6.01A(2)(b)(i) of the Listing Rules (which will come into effect on the Effective Date), the Stock Exchange may cancel the Company's listing if trading in the Shares has remained suspended for 18 continuous months from the Effective Date.

The 18-month period will expire on 31 January 2020 (the "Expiry Date"). If the Company fails to resume trading in the Shares by the Expiry Date, the Listing Department of the Stock Exchange will recommend the Listing Committee of the Stock Exchange to proceed with the cancellation of the Company's listing, subject to the Stock Exchange's right to impose a shorter specific remedial period under Rule 6.10 of the Listing Rules if appropriate.

GENERAL

Trading in the shares of the Company will remain suspended until further notice. Further announcement(s) will be made by the Company as and when appropriate.

Shareholders and potential investors of the Company should exercise caution when dealing in the shares of the Company.

By Order of the board of directors of

China Wah Yan Healthcare Limited

Chan Ka Chung

Chairman

Hong Kong, 31 July 2018

As at the date of this announcement, the board of directors of the Company comprises three executive directors, namely Mr. Chan Ka Chung, Mr. Cheung Wai Kwan and Mr. Wang Jianguo; and four independent non-executive directors, namely, Mr. Chan Yee Ping, Michael, Ms. Hu Xuezhen, Mr. Lam Chun Ho and Mr. Tsang Hung Kei.